Zeaxanthin From Leafy Greens May Supercharge Cancer Immunotherapy
Common eye-health nutrient zeaxanthin strengthens immune T cells and enhances cancer treatment effectiveness in new research.
20 articles
Common eye-health nutrient zeaxanthin strengthens immune T cells and enhances cancer treatment effectiveness in new research.
Japanese scientists engineered hybrid vitamin K molecules that are 3x more potent at regrowing neurons, potentially transforming Alzheimer's treatment.
Experts say the next era of obesity care pairs GLP-1 medications with precision medicine, endoscopic procedures, and surgery for lasting results.
Salk Institute researchers found methionine supplementation dramatically improved survival in infected mice by enhancing kidney filtration of inflammatory molecules.
A clinical trial found testosterone gel plus exercise prevented visceral fat increases in women over 65 recovering from hip fractures.
MIT researchers discover cysteine activates immune cells that boost intestinal stem cells, opening doors to nutrition-based gut therapies.
New AI-discovered peptide mimics Ozempic's weight loss effects but targets only the brain's appetite center, avoiding nausea and muscle loss.
A novel β2 agonist pill boosts fat burning via skeletal muscle, preserving muscle mass while improving blood sugar in early trials.
New research reveals GLP-1 drugs like Ozempic deliver stronger results for 'see-food' eaters than those who eat due to stress or emotions.
A small Brazilian trial found 43% of women taking 2,000 IU vitamin D daily achieved complete cancer remission vs 24% on placebo.
A UC San Diego trial shows ION224 blocks liver fat production, cutting inflammation and scarring in 60% of MASH patients.
A major 6-year European trial found a calorie-reduced Mediterranean diet plus exercise slashed type 2 diabetes risk by nearly a third.
New MUSC research finds EPA in fish oil could weaken brain vessel repair and worsen recovery after repeated mild traumatic brain injuries.
Stanford researchers found genetic variants in ~10% of people that blunt GLP-1 drug effectiveness, pointing toward precision diabetes care.
A proteomics study tracking 3,000 blood proteins reveals fasting's deepest benefits emerge only after 72 hours without food.
New research reveals genetic 'GLP-1 resistance' affects 1 in 10 people, explaining why popular diabetes and weight-loss drugs fail for some patients.
New research finds D2 supplements can lower D3 levels and may lack D3's unique immune-boosting effects, prompting calls to rethink supplementation.
A liver-destroying tapeworm linked to cancer-like cysts has reached the Pacific Northwest, found in one-third of surveyed coyotes near Puget Sound.
Despite being cheap and effective for blood pressure control, salt substitutes remain vastly underused even by those who need them most.
Cutting off biotin halts cancer cell growth by disabling a key enzyme, revealing a promising new therapeutic target.